Zenas BioPharma · 4 days ago
Director, Commercial Supply Chain Planning and Operations
Waltham, MA
Full-time
Hybrid
Director/Executive
$175K/yr - $219K/yr
12+ years expZenas BioPharma is a clinical-stage global biopharmaceutical company committed to developing transformative therapies for autoimmune diseases. The Commercial Supply Chain Planning and Operations Director will lead the planning and execution for the company's first commercial product launch in the U.S. and EU, ensuring seamless product availability and operational readiness.
BiopharmaHealth CarePharmaceutical
Responsibilities
Lead cross-functional commercial supply and launch readiness activities for the first product launch in the US and EU
Develop, drive and maintain detailed launch plans ensuring overall supply chain and CMC readiness for commercial launch
Build and maintain commercial supply models, forecasts, and capacity plans based on market demand, inventory strategies, and lead times
Coordinate with CDMOs to establish production schedules, campaign plans, and batch execution aligned to forecast requirements and contractual commitments
Lead monthly supply planning reviews and provide input into the S&OP process, highlighting risks, opportunities, and recommended actions
Partner with CMC, Quality, Regulatory, and Commercial to align supply strategies with registration timelines, market access, and forecast assumptions
Track and report key supply performance metrics (e.g., service level, plan adherence, capacity utilization, inventory health). Develop and implement supply chain dashboards, reports, and KPIs to support executive decision-making
Partner with Quality and Technical Operations to ensure compliant product release and distribution readiness
Support cost and budget management for commercial supply chain activities, including scenario-based financial impact modeling
Contribute to continuous improvement initiatives for planning systems, tools, and processes
Qualification
Required
Bachelor's degree in Supply Chain, Engineering, Life Sciences, or a related field (MBA or advanced degree preferred)
Minimum of 12+ years in biotech or pharmaceutical supply chain management, with 3+ years in commercial or late-stage launch readiness
Proven experience managing CDMO relationships and external manufacturing operations (Drug Substance, Drug Product and Packaging and Labeling)
Hands-on expertise in supply planning, launch planning, forecasting, and S&OP processes
Strong understanding of GMP manufacturing, regulatory submission impact on supply, and global distribution logistics
Excellent analytical and modeling skills; advanced skills in Excel and/or supply planning tools
Strong project management and cross-functional leadership capabilities
Exceptional communication and presentation skills, with the ability to synthesize complex information for senior stakeholders
Demonstrated ability to thrive in a fast-paced, dynamic, and matrixed environment
Comfortable managing ambiguity and building new processes from the ground up
Ability to work flexible business hours to travel and communicate with global business partners (up to 10-20% of time)
Benefits
Annual performance bonus
Equity
Full range of benefits
Other incentive compensation plans
Company
Zenas BioPharma
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
51-200 employees
H1B Sponsorship
Zenas BioPharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$513MKey Investors
Royalty PharmaEnavate Sciences
2025-10-08Post Ipo Equity· $120M
2025-09-02Post Ipo Debt· $75M
2024-09-13IPO
Leadership Team
Lonnie Moulder Jr
Chairman
Orlando Oliveira
Chief Commercial Officer
Recent News
2026-01-07
2026-01-06
Company data provided by crunchbase